Je. Eyles et al., Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits, J CONTR REL, 63(1-2), 2000, pp. 191-200
We have investigated noninvasive immunization to plague. Recombinant subuni
t antigens, Fl and V from Yersinia pestis, were coencapsulated in biodegrad
able poly(L-lactide) microspheres and intranasally administered to mice ove
r a range of dose levels. Proteins retained antigenicity during, and postmi
croencapsulation as evidenced by immunoblotting and capture enzyme-linked i
mmunosorbent assay protocols. Supporting the rationale that a subunit antig
en based vaccine for plague should contain both the Fl and V antigens, we o
bserved that systemic antibody titres to V were improved by concomitant nas
al immunization with Fl. Conversely, serum titres to Fl were unaffected by
the presence of V in the nasal inoculum. Interestingly, intramuscular injec
tion of Fl augmented humoral immunity to nasally applied V antigen, suggest
ing that Fl adjuvantizes nasally instilled V even when introduced at a spat
ially distinct location. Although the magnitude of the specific serum respo
nse to nasally applied microspheres and equivalent doses of soluble subunit
s was not always directly proportional to administered dose and frequency o
f dosing, generally coencapsulated antigens evoked higher titred serum anti
body responses. Also, when T-cell recall indices were measured they were fo
und to be maximum in microsphere vaccinees. As few as two appropriately tim
ed nasal inoculations of coencapsulated Fl and V afforded complete protecti
on from >100 LD50's inhalational challenge with virulent Y. pestis. These d
ata expand on previous findings from our laboratories, providing further in
sight into the mechanics of safeguarding mice from plague through nasal imm
unization. Further, these results demonstrate that in a murine model, solid
protection from pneumonic plague can be engendered by two intranasal admin
istrations of appropriately formulated recombinant proteins. (C) 2000 Elsev
ier Science B.V. All rights reserved.